A bill for an act relating to the standards of practice relating to the prescribing of certain pain medications.
Impact
If enacted, HSB160 will amend the current standards established by the Iowa Board of Medicine. Physicians will be required to document in the patient’s medical record that they have discussed this crucial information with the patient. This regulation aims to enhance patient awareness and safety regarding the use of potentially addictive medications, thereby seeking to combat the opioid crisis by ensuring patients are better informed about the risks involved.
Summary
House Study Bill 160 addresses the standards of practice for physicians when prescribing certain pain medications, specifically controlled substances such as opioid pain relievers. The bill mandates that prior to issuing an initial prescription of these medications for either acute or chronic pain, and again before the third prescription in the same treatment plan, the physician must have a discussion with the patient or their guardian. This discussion is to cover essential topics such as the risks of addiction, the necessity of the prescription, alternative treatments available, and the potential dangers associated with opioid use.
Contention
The bill could lead to discussions around the sufficiency of the current standards for pain management and whether additional regulations may create barriers for patients in legitimate pain. Supporters may argue that it encourages responsible prescribing practices and prioritizes patient safety. However, opponents may express concerns that such requirements could complicate the prescribing process and hinder access to necessary pain relief for patients with genuine medical needs.
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.
Authorizes visiting advanced practice nurses who are not certified by endorsement in New Jersey to engage in the limited practice of prescribing medications and devices, if they have appropriate educational qualifications.
(New Title) relative to the practice of pharmacy, the dispensing of certain medications by pharmacists, and permitting treatment of certain severe illness under the right to try act.
Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements and revises the uniform controlled substances act in accordance with current standards of professional practice.
Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements and revise the uniform controlled substances act in accordance with current standards of professional practice.
Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements, revises the uniform controlled substances act in accordance with current standards of professional practice and would repeal chapter 37.4 of title 5.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.